Skip to main content

Stem Cell Skin Rejuvenation Therapies In Gwangjin Announced By Lydian Clinic

Lydian Cosmetic Surgery Clinic in Seoul announces its autologous regenerative therapies, including stem cell and exosome treatments for skin rejuvenation.

-- Lydian Cosmetic Surgery Clinic announces its latest stem cell skin therapies, available to patients throughout Gangnam, Gwangjin, and beyond. The treatments have been devised by Dr. Abraham An, recognized as one of the Top 100 Stem Cell Therapy Experts in the World and among the Top 18 Aesthetic Cosmetic Surgeons in Korea, leads the clinic's regenerative medicine department, with over 23 years of clinical experience.

More details can be found at https://www.lydianclinic.com/

South Korea's regenerative medicine legislation, which came into effect in August 2020, opens the door for patients with severe, rare, or incurable conditions to access cell and gene therapies that have demonstrated safety and efficacy in clinical research. This legislative framework reinforces the country's position as a medical innovation hub, particularly in regenerative treatments like those offered at the Lydian Clinic.

Dr. An explains that the treatments rely on exosomes, a nano-scale delivery vehicle for cellular nutrients, as the primary driver of growth and recovery. These exosomes deliver growth factors, proteins, and genetic material to activate collagen and elastin production within the dermis, therefore triggering the skin's natural repair mechanisms, reducing inflammation, and accelerating cellular turnover without surgical intervention or anesthesia.

In addition to his work at the clinic, Dr. Abraham An has trained cosmetic medical students internationally since 2011, teaching his proprietary 5D liposculpting technique at several leading medical academies. Patients at Lydian benefit from his highly structured treatment pathway that begins with an online consultation, during which Dr. An reviews medical history and skin concerns to craft a personalized protocol in line with the patient's unique situation.

The clinic's approach accommodates the schedules of international medical tourists. Multilingual staff provide concierge services that extend from initial consultation through post-treatment recovery, ensuring clear communication and logistical support. Patients receive exosome infusions followed by post-treatment care to support recovery. Many patients opt for multiple sessions to achieve improvements in skin firmness, tone, and texture.

The clinic welcomes international patients, who are also invited to enjoy the cultural landmarks and culinary options that can be found in the area immediately around the clinic in Gangnam. Prospective patients can schedule consultations through the link on the clinic's website or by dialing +82 10 9692 5508 on WhatsApp.

For more information, visit https://www.lydianclinic.com/

Contact Info:
Name: Dr. Abraham An
Email: Send Email
Organization: Lydian Cosmetic Surgery Clinic
Address: 836 Nonhyeon-ro, Sinsa-dong, Gangnam, Seoul, Seoul 06025, Korea, Republic of
Website: https://www.lydianclinic.com/

Source: NewsNetwork

Release ID: 89185285

If there are any problems, discrepancies, or queries related to the content presented in this press release, we kindly ask that you notify us immediately at error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our responsive team will be available round-the-clock to address your concerns within 8 hours and take necessary actions to rectify any identified issues or support you with press release takedowns. Ensuring accurate and trustworthy information is our unwavering commitment.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  213.21
-5.73 (-2.62%)
AAPL  257.46
-2.83 (-1.09%)
AMD  192.43
-7.02 (-3.52%)
BAC  48.64
-0.89 (-1.80%)
GOOG  298.30
-2.61 (-0.87%)
META  644.86
-15.71 (-2.38%)
MSFT  408.96
-1.72 (-0.42%)
NVDA  177.82
-5.52 (-3.01%)
ORCL  152.96
-1.83 (-1.18%)
TSLA  396.73
-8.82 (-2.17%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.